Snapshot: Protocol 56 - Shoulder Dystocia
AUTHORS: George A. Macones, MD, Division of Maternal-Fetal Medicine, Dell Medical School-University of Texas at Austin and Robert B. Gherman, MD, Division of Maternal-Fetal Medicine, WellSpan Health System, York, PA.
SYNOPSIS: In this protocol, Macones and Gherman reviews the pathophysiology, diagnosis, and management of shoulder dystocia. Included are descriptions of extraordinary movements and a list of documentation suggested when a shoulder dystocia is encountered.
Protocols for High-Risk Pregnancies, 7th Edition
As the authors note, shoulder dystocia is unpredictable and reported incidence varies from 0.2% to 3.0%. Risk does increase with birth weight, but up to 60% of shoulder dystocias occur in infants weighing less than 4000 g and only 3.3% of births with weights greater than 4000 g involve this complication. Episiotomy alone will not release an impacted shoulder and cutting a generous episiotomy or proctoepisiotomy should be based on clinical circumstances.
Key Messages:
Buy the book on Wiley.com: Protocols for High-Risk Pregnancies: An Evidence-Based Approach, 7th Edition.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More
Unraveling preeclampsia: Insights into heterogeneity and intravascular inflammation
April 22nd 2024A recent study delved into the intricate clusters of term preeclampsia, shedding light on its diverse manifestations and the pivotal role of intravascular inflammation, paving the way for improved classification and management strategies.
Read More